Form D · Other Health Care
North Texas Renal Management II LLC
Dallas, TX · CIK 0001657576
Offering snapshot reported Jan 18, 2024 · SEC filing
- Reported sold
- $45.8K Offering amount: $653K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 18, 2024 | Initial | $45,800 | No comparison | 1 | SEC filing |
| Jan 19, 2023 | Initial | $84,600 | No comparison | 2 | SEC filing |
| Jan 17, 2023 | Initial | $337,425 | No comparison | 10 | SEC filing |
| Nov 5, 2015 | Initial | $470,175 | No comparison | 64 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-502755
Source: Form D, filed Jan 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Fuquay, M.D. | Director |
| Steven M Gieser, M.D. | Director, Executive |
| Alexander Liang, M.D. | Director |
| Joris M Schuller, Jr., M.D. | Director |
| Joris M. Schuller, M.D. | Director |
| Anupkumar Shetty, M.D. | Director, Executive |
| Geoffrey Walker | Director |
| Geoffrey Walker, M.D. | Director, Executive |
| Venkata Yalamanchili, M.D. | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1505 Lbj Freeway, Suite 700
Dallas, TX, 75234
Dallas, TX, 75234